Hemostasis Today

March, 2026
March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Bruno Pougault: Oral Anticoagulants Are Essential, But Not a ‘Fix-All’
Mar 22, 2026, 14:12

Bruno Pougault: Oral Anticoagulants Are Essential, But Not a ‘Fix-All’

Bruno Pougault, Global Marketing Hemostasis Product Manager at HORIBA, shared on LinkedIn about a recent article by Eva Soler-Espejo et al, published in JAHA:

”Oral anticoagulants: Essential, but not a ‘fix-all’.

A huge thank you to the authors of this recent study in JAHA (DOI: 10.1161/JAHA.125.046694) for highlighting the reality of residual risk.

Even with optimal treatment, the risk of stroke in AFib patients persists.

This research is a vital reminder that we must look beyond the prescription: managing comorbidities and lifestyle remains just as crucial as the medication itself.

Great work by the team for pushing the boundaries of comprehensive cardiovascular care!”

Title: Atherogenic Index of Plasma and Residual Risk in Anticoagulated Patients With Atrial Fibrillation: The Prospective Murcia Atrial Fibrillation Project III Cohort

Authors: Eva Soler-Espejo, Yang Chen, José M. Rivera-Caravaca, María P. Ramos-Bratos, Francisco Marín, Vanessa Roldán, Gregory Y. H. Lip

Read the Full Article on JAHA

Bruno Pougault: Oral Anticoagulants Are Essential, But Not a 'Fix-All'

Stay updated on all scientific advances with Hemostasis Today.